MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Amylyx Pharmaceuticals, Inc. (AMLX)

Amylyx Pharmaceuticals, Inc. (AMLX)

|||

Balance Sheets Overview

Current Ratio
1212.00%
Quick Ratio
1212.00%
Cash Ratio
233.22%
Debt to Asset Ratio
9.60%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
49,326
229,136
226,651
225,178
Marketable securities
201,434
50,632
90,328
118,812
Accounts receivable, net
-
-
88
132
Prepaid expenses and other current assets
5,578
5,256
6,604
9,261
Total current assets
256,338
285,024
323,671
353,383
Total property and equipment
-
-
1,864
-
Less accumulated depreciation
-
-
1,554
-
Property and equipment, net
199
212
310
399
Restricted cash equivalents
986
986
985
983
Operating lease right-of-use assets
4,541
4,881
5,181
5,476
Other assets
-
2,500
-
2,500
Deposits and other assets
2,500
-
2,498
-
Total assets
264,564
293,603
332,645
362,741
Accounts payable
5,533
3,529
3,519
5,339
Accrued expenses
14,609
11,282
17,910
19,471
Operating lease liabilities, current portion
1,008
1,155
1,259
981
Total current liabilities
21,150
15,966
22,688
25,791
Operating lease liabilities, net of current portion
4,247
4,476
4,698
4,954
Total liabilities
25,397
20,442
27,386
30,745
Common stock, 0.0001 par value 300,000,000 shares authorized 111,368,283 and 109,884,502 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
11
11
11
11
Additional paid-in capital
1,075,271
1,065,621
1,056,271
1,049,598
Accumulated deficit
-836,134
-792,711
-751,427
-718,428
Accumulated other comprehensive income
19
240
404
815
Total stockholders' equity
239,167
273,161
305,259
331,996
Total liabilities and stockholders' equity
264,564
293,603
332,645
362,741
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$201,434K (64.11%↑ Y/Y)Cash and cashequivalents$49,326K (-15.08%↓ Y/Y)Prepaid expenses andother current assets$5,578K (-6.43%↓ Y/Y)Total current assets$256,338K (37.16%↑ Y/Y)Operating leaseright-of-use assets$4,541K (-21.87%↓ Y/Y)Deposits and other assets$2,500K Restricted cashequivalents$986K (-32.05%↓ Y/Y)Property and equipment,net$199K (-55.28%↓ Y/Y)Total assets$264,564K (35.95%↑ Y/Y)Total liabilities andstockholders' equity$264,564K (35.95%↑ Y/Y)Total stockholders'equity$239,167K (42.47%↑ Y/Y)Total liabilities$25,397K (-4.95%↓ Y/Y)Accumulated deficit-$836,134K (-22.23%↓ Y/Y)Additional paid-in capital$1,075,271K (26.30%↑ Y/Y)Total currentliabilities$21,150K (-1.28%↓ Y/Y)Operating leaseliabilities, net of current...$4,247K (-19.82%↓ Y/Y)Accumulated othercomprehensive income$19K (-96.55%↓ Y/Y)Common stock, 0.0001par value...$11K (22.22%↑ Y/Y)Accrued expenses$14,609K (-16.35%↓ Y/Y)Accounts payable$5,533K (67.97%↑ Y/Y)Operating leaseliabilities, current portion$1,008K (51.58%↑ Y/Y)